Document is current
Any future updates will be listed below
-
Authors
Jaitner, Annika
Vaudel, Marc
Tsaneva-Atanasova, Krasimira
Njølstad, Pål R.
Jacobsson, Bo
Bowden, Jack
Johansson, Stefan
Freathy, Rachel M.
-
Funding
Funding for this research was provided by:
Faculty of Health and Life Science, University of Exeter
Norges Forskningsråd (#301178, #240413, #315599)
Engineering and Physical Sciences Research Council (EP/T017856/1)
European Research Council (AdG #293574)
Trond Mohn stiftelse (#240413)
Helse Vest Regionalt Helseføretak
Novo Nordisk Fonden (#NNF54741, NNF20OC0063872)
Helse Vest’s Open Research Grant (#912250 , F-12144)
Wellcome Trust (WT220390)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD101669)
- License Information
-
More Information
Article History
Received: 27 October 2023
Accepted: 17 March 2024
First Online: 4 April 2024
Declarations
:
: The establishment of MoBa and initial data collection was based on a licence from the Norwegian Data Protection Agency and approval from The Regional Committees for Medical and Health Research Ethics. The MoBa cohort is currently regulated by the Norwegian Health Registry Act. The current study was approved by the Regional Committees for Medical and Health Research Ethics (no. 2012/67).Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time.
: Not applicable.
: The authors declare no competing interests.
